Claro Advisors’s DexCom DXCM Stock Holding History

Claro Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-56	Closed	-$2K	–	359
2018 Q4	$2K	Buy	+56	New	+$1.78K	﹤0.01%	910

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Claro Advisors's DXCM Position: Q1 2019 in Review

Claro Advisors sold out of DexCom (DXCM) in Q1 2019, closing a stake of 56 shares — an estimated $2K sold.

Claro Advisors first reported a position in DXCM in Q4 2018 and held it in 1 quarter. The position peaked at $2K in Q4 2018. 457 funds tracked by Wall St. Rank hold DXCM as of Q1 2019.

Claro Advisors reported no remaining DexCom position as of Q1 2019 after selling out during the quarter.
Claro Advisors sold 56 DexCom shares in Q1 2019, an estimated $2K.
Claro Advisors first reported a position in DexCom in Q4 2018 and held it in 1 quarter.
Claro Advisors's DexCom position peaked at $2K in Q4 2018.
457 funds tracked by Wall St. Rank held DexCom as of Q1 2019.

Based on Claro Advisors's 13F filing for Q1 2019, filed 10 May 2019.